Role of progesterone in human astrocytomas growth

Current Topics in Medicinal Chemistry

Volumn 11, Issue 13, 2011, Pages 1663-1667

  Cabrera Muñoz, Edith ^a   Hernández Hernández, Olivia Tania ^a   Camacho Arroyo, Ignacio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Astrocytomas; Cell growth; Progesterone; Progesterone receptor isoforms

Indexed keywords

CALCITONIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; GESTAGEN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTIDINE; HISTIDINE CARBOXILASE; LACTOFERRIN; MEDROXYPROGESTERONE; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; ASTROCYTOMA; BINDING AFFINITY; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; FATALITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; GROWTH RATE; HORMONAL THERAPY; HORMONE SYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MENINGIOMA; MITOSIS RATE; NEOPLASM; NERVE CELL EXCITABILITY; NONHUMAN; OVULATION; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; SYMPTOM; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; WESTERN BLOTTING;

ASTROCYTOMA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MIFEPRISTONE; PROGESTERONE; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE;

EID: 79959951709     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796117685     Document Type: Article

References (50)

1. Carroll, R. S.; Zhang, J.; Dashner, K.; Sar, M.; Black, P. M. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery, 1995, 37(3), 496-503.
2. Grunberg, S. M.; Weiss, M. H.; Spitz, I. M.; Ahmadi, J.; Sadun, A.; Russell, C. A.; Lucci, L.; Stevenson, L. L. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J. Neurosurg., 1991, 74(6), 861-866.
3. Khalid, H.; Shibata, S.; Kishikawa, M.; Yasunaga, A.; Iseki, M.; Hiura, T. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer, 1997, 80(11), 2133-2140.
4. Riemenschneider, M. J.; Reifenberger, G. Astrocytic tumors. Recent Results Cancer Res., 2009, 171, 3-24.
5. Camacho-Arroyo, I.; Gonzalez-Aguero, G.; Gamboa-Dominguez, A.; Cerbon, M. A.; Ondarza, R. Progesterone receptor isoforms expression pattern in human chordomas. J. Neurooncol., 2000, 49(1), 1-7.
6. Kastner, P.; Krust, A.; Turcotte, B.; Stropp, U.; Tora, L.; Gronemeyer, H.; Chambon, P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo. J., 1990, 9 (5), 1603-1614.
7. Leonhardt, S. A.; Boonyaratanakornkit, V.; Edwards, D. P. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids, 2003, 68 (10-13), 761-770.
8. Kraus, W. L.; Katzenellenbogen, B. S. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Endocrinology, 1993, 132(6), 2371-2379.
9. Kraus, W. L.; Montano, M. M.; Katzenellenbogen, B. S. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters. Mol. Endocrinol., 1993, 7(12), 1603-1616.
10. Conneely, O. M.; Jericevic, M. Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms. Rev. Endocr. Metab. Disord., 2002, 3 (3),201-9.
11. Edwards, D. P.; Wardell S. E.; Boonyaratanakornkit V. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. J. Steroid. Biochem. Mol. Biol., 2002, 83(1-5), 173-186.
12. Lange, C. A.; Shen, T.; Horwitz, K. B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. USA, 2000, 97(3), 1032-1037.
13. Turgeon, J. L.; Waring, D. W. Progesterone regulation of the progesterone receptor in rat gonadotropes. Endocrinology, 2000, 141(9), 3422-3429.
14. Camacho-Arroyo, I.; Villamar-Cruz, O.; Gonzalez-Arenas, A.; Guerra-Araiza, C. Participation of the 26S proteasome in the regulation of progesterone receptor concentrations in the rat brain. Neuroendocrinology, 2002, 76(5), 267-271.
15. Rousseau, A.; Mokhtari, K.; Duyckaerts, C. The 2007 WHO classification of tumors of the central nervous system-what has changed? Curr. Opin. Neurol., 2008, 21(6), 720-727.
16. Daumas-Duport, C.; Scheithauer, B.; O'Fallon, J.; Kelly, P. Grading of astrocytomas. A simple and reproducible method. Cancer, 1988, 62(10), 2152-2165.
17. Ichimura, K.; Ohgaki, H.; Kleihues, P.; Collins, V. P. Molecular pathogenesis of astrocytic tumours. J. Neurooncol., 2004, 70(2), 137-160.
18. Konstantinova, I.M.; Tsimokha, A.S.; Mittenberg, A.G. Role of proteasomes in cellular regulation. Int. Rev. Cell Mol. Biol., 2008, 267, 59-124.
19. Fasanaro, P.; Capogrossi, M. C.; Martelli, F. Regulation of the endothelial cell cycle by the ubiquitin-proteasome system. Cardiovasc. Res., 2010, 85(2),272-280.
20. Legnani, F.G.; Pradilla, G.; Thai, Q. A.; Fiorindi, A.; Recinos, P. F.; Tyler, B. M.; Gaini, S. M.; DiMeco, F.; Brem, H.; Olivi, A. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers. Neurooncol, 2006, 77(3), 225-232.
21. Yu, C.; Friday, B. B.; Yang, L.; Atadja, P.; Wigle, D.; Sarkaria, J.; Adjei, A. A. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. Neuro-Oncol 2008, 10, 309-319.
22. Sager, G.; Orbo, A.; Jaeger, R.; Engstrom, C. Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides. J. Steroid. Biochem. Mol. Biol., 2003, 84(1), 1-8.
23. Olson, J. J.; Beck, D. W.; Schlechte, J.; Loh, P. M. Hormonal manipulation of meningiomas in vitro. J. Neurosurg., 1986, 65(1), 99-107.
24. Piroli, G.; Torres, A.; Grillo, C.; Lux-Lantos, V.; Aoki, A.; De Nicola, A. F. Mechanisms in progestin antagonism of pituitary tumorigenesis. J. Steroid. Biochem. Mol. Biol., 1998, 64(1-2), 59-67.
25. Altinoz, M. A.; Bilir, A.; Ozar, E.; Onar, F. D.; Sav, A. Medroxyprogesterone acetate alone or synergistic with chemotherapy suppresses colony formation and DNA synthesis in C6 glioma in vitro. Int. J. Dev. Neurosci., 2001, 19(6), 541-547.
26. Pinski, J.; Halmos, G.; Shirahige, Y.; Wittliff, J. L.; Schally, A. V. Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486. J. Clin. Endocrinol. Metab., 1993, 77(5), 1388-1392.
27. Gonzalez-Aguero, G.; Gutierrez, A. A.; Gonzalez-Espinosa, D.; Solano, J. D.; Morales, R.; Gonzalez-Arenas, A.; Cabrera-Munoz, E.; Camacho-Arroyo, I. Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines. Endocrine, 2007, 32(2), 129-135.
28. Stening, K.; Eriksson, O.; Wahren, L.; Berg, G.; Hammar, M.; Blomqvist, A. Pain sensations to the cold pressor test in normally menstruating women: comparison with men and relation to menstrual phase and serum sex steroid levels. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293(4), R1711-1716.
29. Assimakopoulou, M.; Sotiropoulou-Bonikou, G.; Maraziotis, T.; Varakis, J. Does sex steroid receptor status have any prognostic or predictive significance in brain astrocytic tumors? Clin. Neuropathol., 1998, 17 (1), 27-34.
30. Brandis, A.; Mirzai, S.; Tatagiba, M.; Walter, G. F.; Samii, M.; Ostertag, H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery, 1993, 33, (2), 212-217.
31. Hsu, D. W.; Efird, J. T.; Hedley-Whyte, E. T. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J. Neurosurg., 1997, 86(1), 113-120.
32. Gonzalez-Aguero, G.; Ondarza, R.; Gamboa-Dominguez, A.; Cerbon, M. A.; Camacho-Arroyo, I. Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res. Bull., 2001, 56(1), 43-48.
33. Richer, J. K.; Jacobsen, B. M.; Manning, N. G.; Abel, M. G.; Wolf, D. M.; Horwitz, K. B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem., 2002, 277(7), 5209-5218.
34. Mulac-Jericevic, B.; Mullinax, R. A.; DeMayo, F. J.; Lydon, J. P.; Conneely, O. M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science, 2000, 289(5485), 1751-1754.
35. Camacho-Arroyo, I.; Guerra-Araiza, C.; Cerbon, M. A. Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain. Neuroreport, 1998, 9, (18), 3993-3996.
36. Guerra-Araiza, C.; Villamar-Cruz, O.; Gonzalez-Arenas, A.; Chavira, R.; Camacho-Arroyo, I. Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J. Neuroendocrinol., 2003, 15(10), 984-990.
37. Kraus, W. L.; Montano, M. M.; Katzenellenbogen, B. S. Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol. Endocrinol., 1994, 8(8), 952-969.
38. Weigel, N. L. Steroid hormone receptors and their regulation by phosphorylation. Biochem. J., 1996, 319 (Pt 3), 657-667.
39. Cabrera-Munoz, E.; Gonzalez-Arenas, A.; Saqui-Salces, M.; Camacho, J.; Larrea, F.; Garcia-Becerra, R.; Camacho-Arroyo, I. Regulation of progesterone receptor isoforms content in human astrocytoma cell lines. J. Steroid. Biochem. Mol. Biol., 2009, 113 (1-2), 80-84.
40. Giangrande, P. H.; McDonnell, D. P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog. Horm. Res., 1999, 54, 291-313.
41. Hovland, A. R.; Powell, R. L.; Takimoto, G. S.; Tung, L.; Horwitz, K. B. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J. Biol. Chem., 1998, 273(10), 5455-5460.
42. Nicholas, M. K.; Lukas, R. V.; Jafri, N. F.; Faoro, L.; Salgia, R. Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas. Clin. Cancer Res., 2006, 12(24), 7261-7270.
43. Omuro, A. M.; Faivre, S.; Raymond, E. Lessons learned in the development of targeted therapy for malignant gliomas. Mol. Cancer Ther., 2007, 6 (7), 1909-1919.
44. Oka, N.; Soeda, A.; Inagaki, A.; Onodera, M.; Maruyama, H.; Hara, A.; Kunisada, T.; Mori, H.; Iwama, T. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun., 2007, 360(3), 553-559.
45. Mueller, M. D.; Vigne, J. L.; Pritts, E. A.; Chao, V.; Dreher, E.; Taylor, R. N. Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertil Steril., 2003, 79(2), 386-392.
46. Zhao, S.; Chen, X.; Lu, X.; Yu, Y.; Feng, Y. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Gynecol. Oncol., 2007, 105(1), 45-54.
47. Liang, Y.; Hyder, S. M. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology, 2005, 146(8), 3632-3641.
48. Lockwood, C. J.; Krikun, G.; Runic, R.; Schwartz, L. B.; Mesia, A. F.; Schatz, F. Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab., 2000, 85(1), 297-301.
49. Faivre, E. J.; Daniel, A. R.; Hillard, C. J.; Lange, C. A. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol. Endocrinol., 2008, 22(4), 823-837.
50. Knizetova, P.; Ehrmann, J.; Hlobilkova, A.; Vancova, I.; Kalita, O.; Kolar, Z.; Bartek, J. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGFVEGFR2 (KDR) interplay. Cell Cycle, 2008, 7 (16), 2553-2561.